• Home
  • Stocks
  • Sun Pharma Advanced Research Company Ltd.

Sun Pharma Advanced Research Company Ltd.
Snapshot View

View in App

Prices View details >>

222.30 -8.80 ▼-3.8%

30 September 2022, 12:47:59 PM
Volume: 1,545,443

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.sparc.life
Market Cap 6,042.51 Cr.
Enterprise Value(EV) 6,369.13 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) -8.25 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-06
Industry PE 31.29 Trailing Twelve Months Ending 2022-06
Book Value / Share -10.50 Trailing Twelve Months Ending 2022-06
Price to Book Value -21.17 Calculated using Price: 222.25
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 27.19 Cr. 271,878,966 Shares
FaceValue 1
Company Profile
The company is engaged in the pharmaceutical research and development. The company's core focus is innovation and new product development for global markets. SPARC undertakes projects in research and technology for new chemical entities (NCE's) or new molecules, and novel drug delivery systems (NDDS).

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-3.81%
1 Week
+2.37%
1 Month
-3.33%
3 Month
+6.31%
6 Month
-25.70%
1 Year
-24.86%
2 Year
+27.98%
5 Year
-41.53%
10 Year
+179.59%

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 24.62 -33.17 -109.16 -127.40 -156.84 -74.72 -225.08
Return on Capital Employed (%) 24.02 -31.74 -71.37 -94.66 -113.05 -59.95 -178.95 -254.10 -225.57
Return on Assets (%) 15.29 -23.65 -44.68 -53.72 -66.85 -40.89 -93.11 -60.18 -79.80

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds 108 139 100 32 158 185 296 -19 -168 31
Non Curr. Liab. 6 9 10 10 10 12 7 56 165 77
Curr. Liab. 94 39 37 125 108 116 95 235 233 171
Minority Int.
Equity & Liab. 209 188 147 167 277 313 398 273 230 280
Non Curr. Assets 69 77 83 99 118 138 141 205 167 209
Curr. Assets 139 110 63 67 158 175 257 67 63 71
Misc. Exp. not W/O 1 1 0 1
Total Assets 209 188 147 167 277 313 398 273 230 280

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 167 156 161 181 78 183 77 253 137 144
Other Income 10 3 3 14 5 14 10 5 7 7
Total Income 177 159 164 195 83 196 87 258 144 150
Total Expenditure -134 -191 -224 -304 -321 -334 -387 -388 -324 -355
PBIDT 43 -32 -60 -109 -238 -138 -300 -130 -180 -204
Interest -6 0 -2 -2 0 0 -3 -11 -13 -10
Depreciation -4 -7 -8 -8 -8 -8 -9 -11 -10 -10
Taxation -4
Exceptional Items 49
PAT 30 -40 -70 -119 -197 -145 -312 -151 -203 -224
Adjusted EPS 1 -2 -3 -5 -8 -6 -12 -6 -7 -8

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. -95 37 -41 -44 -128 -183 -172 -211 -152 -208
Cash Fr. Inv. -99 44 53 -13 -7 -105 -102 155 2 -29
Cash Fr. Finan. 194 -81 -1 51 194 224 274 55 159 229
Net Change 0 0 11 -7 60 -63 0 9 -8
Cash & Cash Eqvt 0 0 11 4 64 0 0 0 9 1

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 68.46 68.46 68.46 68.46 68.46 68.10 68.10 69.09 69.09
Public 31.54 31.54 31.54 31.54 31.54 31.90 31.90 30.91 30.91
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 1.90 1.90 0.75 2.29 2.29 2.29 2.29 2.18 2.18

Announcements View Details >>

Thu, 29 Sep 2022
Spurt in Volume
SPARC : Significant increase in volume has been observed in Sun Pharma Advanced Research Company Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.
Thu, 29 Sep 2022
Closure of trading window
Sun Pharma Advanced Research Company Limited has informed the Exchange about Closure of trading window
Thu, 29 Sep 2022
Press Release
Sun Pharma Advanced Research Company Limited has informed the Exchange about press release dated 29-Sep-2022 titled SPARC to provide Update on Clinical Programs and R&D Pipeline

Technical Scans View Details >>

Thu, 29 Sep 2022
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Close Crossing Last Week High Close Crossing Last Week High
Close Crossing Last Month Close From Below Close Crossing Last Month Close From Below

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 223,330.10 943.10 +1.3%
Divi's Laboratories Ltd. 97,819.86 3,699.10 +0.2%
Cipla Ltd. 90,339.79 1,117.00 +0.1%
Dr. Reddy's Laboratories Ltd. 72,565.89 4,331.05 -0.7%
Apollo Hospitals Enterprise Ltd. 63,143.03 4,386.80 -0.1%
Torrent Pharmaceuticals Ltd. 52,359.20 1,548.10 +0.2%
Abbott India Ltd. 40,610.60 19,148.25 -0.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 57.42 943.10 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-06 31.50 3,699.10 +0.2%
Cipla Ltd. Consolidated 2022-06 36.30 1,117.00 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 24.26 4,331.05 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 71.47 4,386.80 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 65.37 1,548.10 +0.2%
Abbott India Ltd. Standalone 2022-06 50.22 19,148.25 -0.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.46 943.10 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-06 7.87 3,699.10 +0.2%
Cipla Ltd. Consolidated 2022-06 4.20 1,117.00 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.58 4,331.05 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.63 4,386.80 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.19 1,548.10 +0.2%
Abbott India Ltd. Standalone 2022-06 13.62 19,148.25 -0.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 943.10 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,699.10 +0.2%
Cipla Ltd. Consolidated 2022-03 0.04 1,117.00 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,331.05 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,386.80 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,548.10 +0.2%
Abbott India Ltd. Standalone 2022-03 0.00 19,148.25 -0.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 943.10 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,699.10 +0.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,117.00 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,331.05 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,386.80 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,548.10 +0.2%
Abbott India Ltd. Standalone 2022-03 29.95 19,148.25 -0.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 943.10 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,699.10 +0.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,117.00 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,331.05 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,386.80 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,548.10 +0.2%
Abbott India Ltd. Standalone 2022-03 29.95 19,148.25 -0.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 943.10 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,699.10 +0.2%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,117.00 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,331.05 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,386.80 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,548.10 +0.2%
Abbott India Ltd. Standalone 2022-03 4,919.27 19,148.25 -0.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 943.10 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,699.10 +0.2%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,117.00 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,331.05 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,386.80 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,548.10 +0.2%
Abbott India Ltd. Standalone 2022-03 798.70 19,148.25 -0.2%

FAQ's On Sun Pharma Advanced Research Company Ltd.

What is Sun Pharma Adv. Res share price?
Can I buy Sun Pharma Adv. Res shares now?
What is the Market Cap of Sun Pharma Adv. Res?
What is the 52 Week High and Low of Sun Pharma Adv. Res?
What is the trend of Sun Pharma Adv. Res share price?